Name:  ___                       Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Obesity
 
Major Surgical or Invasive Procedure:
laparoscopic sleeve gastrectomy

 
History of Present Illness:
___ woman with longstanding morbid
obesity refractory to attempts at weight loss by nonoperative
means.  Her preoperative weight on screening with us was 317.1
pounds.  Given her height, this translates to a body mass index
of 57.2 kg/m2.  Previous unsuccessful attempts at weight loss
have included multiple attempts at Weight Watchers, ___ diet,
work with a personal ___.  Unfortunately, she has been able
to achieve lasting weight loss results.  She has been 
considering
weight loss surgery for sometime now, does not like the gastric
bypass, feels it a bit too drastic, prefers sleeve gastrectomy,
although she was considering gastric banding.
 
Past Medical History:
Past Medical History:
1.  Hypertension.
2.  Moderate obstructive sleep apnea requiring CPAP.
3.  Mild hyperuricemia.
4.  History of vitamin D deficiency.
5.  History of infertility.

Past Surgical History:  Right foot surgery, ganglion, ___.
 
Social History:
___
Family History:
Father passed away at ___ with heart disease, hyperlipidemia and 
obesity.  Mother has myasthenia ___.
 
Physical Exam:
VS:  98.8   127/75   94   18   98RA
GEN: AA&O x 3, NAD, calm, cooperative.  
HEENT: (-)LAD, mucous membranes moist, EOMI  
CHEST: Clear to auscultation bilaterally, (-) cyanosis.  
ABDOMEN: soft, diffuse tenderness, incision sites are c/d/i 
covered with steri-strips  
EXTREMITIES: Warm, well perfused, no edema
 
Pertinent Results:
___ 07:34PM BLOOD Hct-38.9
___ 04:58AM BLOOD Hct-36.5

IMAGING:
___ UGI
No evidence of leak or obstruction.
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was evaluated by 
anaesthesia.  
The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
GI/GU/FEN: The patient was initially kept NPO. On POD 1 the 
patient had an upper GI series which revealed no leak. As a 
result, the patient was started on a stage 1 bariatric diet, 
which the patient tolerated well. Subsequently, the patient was 
advanced to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.  
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  

At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 40 mg PO BID 
2. NIFEdipine CR 60 mg PO DAILY 
3. EPINEPHrine (EpiPEN) 0.3 mg IM ONCE MR1 
4. spironolacton-hydrochlorothiaz ___ mg oral DAILY 
5. Bisacodyl 5 mg PO DAILY:PRN constipation 
6. Acetaminophen 650 mg PO Q6H:PRN pain 
7. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation 
RX *docusate sodium [Diocto] 50 mg/5 mL 10 mL by mouth twice a 
day Refills:*0
3. Ondansetron 4 mg PO Q8H:PRN nausea 
RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours 
Disp #*30 Tablet Refills:*0
4. OxycoDONE Liquid ___ mg PO Q4H:PRN pain. 
RX *oxycodone 5 mg/5 mL ___ mL by mouth every four (4) hours 
Refills:*0
5. Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 mL by mouth twice a day 
Refills:*1
6. Simethicone 40-80 mg PO QID:PRN gas pain 
RX *simethicone 80 mg ___ tablet by mouth four times a day 
Disp #*30 Tablet Refills:*0
7. Bisacodyl 5 mg PO DAILY:PRN constipation 
8. EPINEPHrine (EpiPEN) 0.3 mg IM ONCE MR1 
9. Lisinopril 40 mg PO BID 
10. NIFEdipine CR 60 mg PO DAILY 
11. spironolacton-hydrochlorothiaz ___ mg oral DAILY 
12. Vitamin D ___ UNIT PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
status post laparoscopic sleeve gastrectomy
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Please call your surgeon or return to the emergency department 
if you develop a fever greater than 101.5, chest pain, shortness 
of breath, severe abdominal pain, pain unrelieved by your pain 
medication, severe nausea or vomiting, severe abdominal 
bloating, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness or swelling around your 
incisions, or any other symptoms which are concerning to you.  

Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum  
Resume your home medications, CRUSH ALL PILLS.  

You will be starting some new medications:  
1. You are being discharged on medications to treat the pain  
from your operation. These medications will make you drowsy and  

impair your ability to drive a motor vehicle or operate  
machinery safely. You MUST refrain from such activities while  
taking these medications.  
2. You should begin taking a chewable complete multivitamin with 
 
minerals. No gummy vitamins.  
3. You will be taking Zantac liquid ___ mg twice daily for one  
month. This medicine prevents gastric reflux.  
4. You should take a stool softener, Colace, twice daily for  
constipation as needed, or until you resume a normal bowel  
pattern.  
5. You must not use NSAIDS (non-steroidal anti-inflammatory  
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and  
Naproxen. These agents will cause bleeding and ulcers in your  
digestive system.  
6. You are being prescribed Zofran 4mg that you can take every 8 
hours as needed for nausea.
7. Simethicone was prescribed and you can take up to four times 
a day to relieve gas pain.

Activity:  
No heavy lifting of items ___ pounds for 6 weeks. You may  
resume moderate exercise at your discretion, no abdominal  
exercises.  

Wound Care:  
You may shower, no tub baths or swimming.  
If there is clear drainage from your incisions, cover with  
clean, dry gauze.  
Your steri-strips will fall off on their own. Please remove any  

remaining strips ___ days after surgery.  

Please call the doctor if you have increased pain, swelling,  
redness, or drainage from the incision sites.  
 
Followup Instructions:
___